SpectrumX confirms scientific advice meeting with MHRA, proposed timeline for human clinical trials for ground-breaking medicine SPX-001
The Company identifies critical milestones required to commence clinical trial programme London, United Kingdom, 8 August 2022: SpectrumX, a UK-based healthcare and pharmaceutical company, is pleased to announce that is has a date for a scientific advice meeting with the UK Medicines and Healthcare products Regulatory Agency (MHRA) to discuss its human clinical trial programme. SpectrumX […]